Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/29/2002US6472517 Nucleic acids encoding human CIDE-B protein and polymorphic markers thereof
10/29/2002US6472515 Response element
10/29/2002US6472512 Keratinocyte derived interferon
10/29/2002US6472510 CD40 receptor ligands
10/29/2002US6472509 Feline cytokine protein
10/29/2002US6472508 Human tumor suppressor
10/29/2002US6472506 Polysaccharide-peptide-conjugates
10/29/2002US6472505 Treatment of physiological conditions capable of being modulated by agonist or antagonist activity on parathyroid hormone receptors
10/29/2002US6472504 Inhibitors of collagen assembly
10/29/2002US6472400 Advanced gylcation end-product intermediaries and post-Amadori inhibition
10/29/2002US6472377 Use of YNES, essential bacterial genes and polypeptides
10/29/2002US6472369 Anticancer compounds and methods
10/29/2002US6472368 Compounds and methods for modulating adhesion molecule function
10/29/2002US6472367 Compounds and methods for modulating OB-cadherin mediated cell adhesion
10/29/2002US6472212 Methods and compositions for genetically modifying primate bone marrow cells
10/29/2002US6472211 Amplification of transcription of preferential genes; obtain cell, incubate with regulatory protein, monitor propagation of cells
10/29/2002US6472209 Using polyamide nucleic acid oligomers to engender a biological response
10/29/2002US6472208 Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
10/29/2002US6472204 Methods for retroviral mediated gene transfer employing molecules, or mixtures thereof, containing retroviral binding domains and target cell binding domains
10/29/2002US6472197 GRB2 associating polypeptides and nucleic acids encoding therefor
10/29/2002US6472194 Directly extracting a sample of mammalian or fish muscle tissue with an aqueous disodium phosphate solution; and recovering thromboplastin in liquid extract separated from sample muscle tissue
10/29/2002US6472184 Providing 2 or more linkable oligonucleotides which in a continuous arrangement and after linkage can form a primary strand, and one or more nonlinkabel oligonucleotides which contains two adjoing regions for further linking
10/29/2002US6472183 Immunity against Actinobacillus pleuropneumoniae's RTX toxins APX
10/29/2002US6472181 Hybrid matrix implants and explants
10/29/2002US6472180 A polynucleotide which encodes a truncated fragment of the hcv ns3 (hepatitis c virus)ns3 protein helicase fragment, such truncated fragment retaining helicase activity and having about 50 amino acids of carboxy terminus deleted
10/29/2002US6472179 Nucleotide sequences coding fusion protein for use in the treatment of osteoporosis, cancers, and cachexia
10/29/2002US6472178 Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof
10/29/2002US6472174 Polypeptides bind to the hek or elk receptor, the nucleic acids encoding such polypeptides; genetic engineering
10/29/2002US6472173 Chemokine receptor obtained from a cDNA library of fetal liver-spleen
10/29/2002US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002US6472171 Expression of procollagen in yeast
10/29/2002US6472170 BCL-Xy, a novel BCL-X isoform, and uses related thereto
10/29/2002US6472151 Method of screening for compounds that modulate the activity of a molecular target
10/29/2002US6472146 Methods for identification on internalizing ligands and identification of known and putative ligands
10/29/2002US6472143 Determining the amount of the complex in a sample and correlating the amount to the presence or absence of a tumor
10/29/2002US6472142 Providing a cell with apoptin which interferes with bip/grp78-mediated apoptosis inhibiting activity; antitumor therapy
10/29/2002US6472140 α-2- macroglobulin therapies and drug screening methods for Alzheimer's disease.
10/29/2002US6471972 Cosmetic treatment method for fighting against skin ageing effects
10/29/2002US6471967 Recombinant intracellular pathogen vaccines and methods for use
10/29/2002US6471966 Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof
10/29/2002US6471964 Designated as structural protein-1 (sp-1), the isolated sp-1 protein, and use of the nucleic acid and/or protein for diagnostic or vaccine purposes
10/29/2002US6471962 Monoclonal antibodies for infectious bursal disease, vaccines and assays for use therewith
10/29/2002US6471960 Methods for the prevention or treatment of alzheimer's disease
10/29/2002US6471957 Canine IL-4 immunoregulatory proteins and uses thereof
10/29/2002US6471956 Ob polypeptides, modified forms and compositions thereto
10/29/2002US6471500 Using a mammalian cell culture medium completely free of nonrecombinant mammalian proteins which are not derived from the host cells.
10/29/2002EP1144613A4 Methods for making proteins containing free cysteine residues
10/29/2002EP0960196A4 Novel receptor that causes cell death
10/29/2002CA2215922C Methods for screening compounds for estrogenic activity
10/29/2002CA2212747C Mhc-antigen complexes for detecting and purifying antigen-specific t cells
10/29/2002CA2173102C Dna sequence coding for a bmp receptor
10/29/2002CA2101325C Cell-free and whole cell ice nucleators and process for their production
10/29/2002CA2094481C Processes for the preparation of amylase inhibitor
10/29/2002CA2063431C Receptors for fibroblast growth factors
10/29/2002CA2060034C Tumour growth-inhibiting somatostatin analogues, pharmaceutical compositions containing them and process for preparing same
10/29/2002CA2045552C Cancer related haptoglobin
10/29/2002CA2033969C Albumin preparation and process for producing same
10/28/2002EP0831872A4 Polypeptide compounds that form beta sheets
10/24/2002WO2002084297A1 Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders
10/24/2002WO2002084286A1 Screening method
10/24/2002WO2002083956A1 Compositions and methods for the therapy and diagnosis of breast cancer
10/24/2002WO2002083946A1 Method of examining allergic disease
10/24/2002WO2002083945A2 Diagnosis and treatment of cancer: i
10/24/2002WO2002083934A1 P2yac receptor involved in platelet aggregation
10/24/2002WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002WO2002083925A2 Papaya ringspot virus genes
10/24/2002WO2002083921A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
10/24/2002WO2002083919A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
10/24/2002WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002WO2002083915A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
10/24/2002WO2002083914A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
10/24/2002WO2002083913A1 Use of b-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
10/24/2002WO2002083912A2 Production of apomictic seed
10/24/2002WO2002083911A1 Production of plants with increased tolerance to drought stress or with increased transpiration
10/24/2002WO2002083908A1 Method for reversible inhibition of gene expression by modified ribonucleoproteins
10/24/2002WO2002083907A1 Process for producing target polypeptide by using uspa
10/24/2002WO2002083906A1 Mhc tetramers
10/24/2002WO2002083903A2 West nile virus epitopes and uses thereof
10/24/2002WO2002083902A2 Adenovirus serotype 30 (ad30) fiber protein and uses thereof
10/24/2002WO2002083901A2 Plant growth regulating genes, proteins and uses thereof
10/24/2002WO2002083900A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/24/2002WO2002083899A1 Cancer-associated genes
10/24/2002WO2002083898A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002WO2002083897A1 Transgenic non-human animals for pharmacological and toxicological studies
10/24/2002WO2002083896A2 Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
10/24/2002WO2002083895A2 New gene from crassostera gigas
10/24/2002WO2002083888A2 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
10/24/2002WO2002083881A1 Methods for detecting and adjusting replication of hepatitis b virus and for preparing mutated virus strains with altered replication efficiency
10/24/2002WO2002083876A2 Secretory molecules
10/24/2002WO2002083874A2 Endothelial cell expression patterns
10/24/2002WO2002083866A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
10/24/2002WO2002083860A2 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
10/24/2002WO2002083859A2 Surface proteins of streptococcus pyogenes
10/24/2002WO2002083858A2 Methods to inhibit viral replication
10/24/2002WO2002083857A2 68723, sodium/glucose cotransporter family members and uses therefor
10/24/2002WO2002083856A2 Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof
10/24/2002WO2002083855A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002WO2002083853A2 Method for enhancing the translation and expression of recombinant proteins
10/24/2002WO2002083851A2 Vegf fusion proteins